Skip Nav Destination
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning
Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma
Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point
Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation
Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study
Issue Archive
September 15 2004
Table of Contents
INSIDE BLOOD
PERSPECTIVES
ERRATA
REVIEW ARTICLES
CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC TRIALS
Reduced-intensity allogeneic hematopoietic stem cell transplantation for myelodysplastic syndrome and acute myeloid leukemia with multilineage dysplasia using fludarabine, busulphan, and alemtuzumab (FBC) conditioning
Clinical Trials & Observations
Aloysius Y. L. Ho,Antonio Pagliuca,Michelle Kenyon,Jane E. Parker,Aleksandar Mijovic,Stephen Devereux,Ghulam J. Mufti
Outcome with the hyper-CVAD regimens in lymphoblastic lymphoma
Clinical Trials & Observations
Deborah A. Thomas,Susan O'Brien,Jorge Cortes,Francis J. Giles,Stefan Faderl,Srdan Verstovsek,Alessandra Ferrajoli,Charles Koller,Miloslav Beran,Sherry Pierce,Chul S. Ha,Fernando Cabanillas,Michael J. Keating,Hagop Kantarjian
GENE THERAPY
Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas
Clinical Trials & Observations
Reinhard Dummer,Jessica C. Hassel,Friederike Fellenberg,Stefan Eichmüller,Tanja Maier,Philippe Slos,Bruce Acres,Pascal Bleuzen,Vincent Bataille,Patrick Squiban,Günter Burg,Mirjana Urosevic
HEMATOPOIESIS
Extracellular nucleotides are potent stimulators of human hematopoietic stem cells in vitro and in vivo
Roberto M. Lemoli,Davide Ferrari,Miriam Fogli,Lara Rossi,Cinzia Pizzirani,Sylvia Forchap,Paola Chiozzi,Diletta Vaselli,Francesco Bertolini,Thomas Foutz,Michela Aluigi,Michele Baccarani,Francesco Di Virgilio
HEMOSTASIS, THROMBOSIS, AND VASCULAR BIOLOGY
IMMUNOBIOLOGY
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point
Clinical Trials & Observations
Alexandra Trkola,Herbert Kuster,Christine Leemann,Annette Oxenius,Catherine Fagard,Hansjakob Furrer,Manuel Battegay,Pietro Vernazza,Enos Bernasconi,Rainer Weber,Bernard Hirschel,Sebastian Bonhoeffer,Huldrych F. Günthard,for the Swiss HIV Cohort Study
Characterization of new human CD20 monoclonal antibodies with potent cytolytic activity against non-Hodgkin lymphomas
Jessica L. Teeling,Ruth R. French,Mark S. Cragg,Jeroen van den Brakel,Marielle Pluyter,Haichun Huang,Claude Chan,Paul W. H. I. Parren,C. Erik Hack,Michael Dechant,Thomas Valerius,Jan G. J. van de Winkel,Martin J. Glennie
NEOPLASIA
Identifying and characterizing a novel activating mutation of the FLT3 tyrosine kinase in AML
Clinical Trials & Observations
Jingrui Jiang,J. Guillermo Paez,Jeffrey C. Lee,Ronghai Bo,Richard M. Stone,Daniel J. DeAngelo,Ilene Galinsky,Brian M. Wolpin,Anna Jonasova,Paula Herman,Edward A. Fox,Titus J. Boggon,Michael J. Eck,Ellen Weisberg,James D. Griffin,D. Gary Gilliland,Matthew Meyerson,William R. Sellers
PHAGOCYTES
An endothelial laminin isoform, laminin 8 (α4β1γ1), is secreted by blood neutrophils, promotes neutrophil migration and extravasation, and protects neutrophils from apoptosis
Zenebech Wondimu,Tarekegn Geberhiwot,Sulev Ingerpuu,Erkki Juronen,Xun Xie,Lennart Lindbom,Masayuki Doi,Jarkko Kortesmaa,Jill Thyboll,Karl Tryggvason,Bengt Fadeel,Manuel Patarroyo
RED CELLS
TRANSPLANTATION
Prognostication of survival using cardiac troponins and N-terminal pro-brain natriuretic peptide in patients with primary systemic amyloidosis undergoing peripheral blood stem cell transplantation
Clinical Trials & Observations
Angela Dispenzieri,Morie A. Gertz,Robert A. Kyle,Martha Q. Lacy,Mary F. Burritt,Terry M. Therneau,Joseph P. McConnell,Mark R. Litzow,Dennis A. Gastineau,Ayalew Tefferi,David J. Inwards,Ivana N. Micallef,Stephen M. Ansell,Luis F. Porrata,Michelle A. Elliott,William J. Hogan,S. Vincent Rajkumar,Rafael Fonseca,Philip R. Greipp,Thomas E. Witzig,John A. Lust,Steven R. Zeldenrust,Denise S. Snow,Susan R. Hayman,Christopher G. A. McGregor,Allan S. Jaffe
Improvement in quality of life of patients with AL amyloidosis treated with high-dose melphalan and autologous stem cell transplantation
Clinical Trials & Observations
David C. Seldin,Jennifer J. Anderson,Vaishali Sanchorawala,Karim Malek,Daniel G. Wright,Karen Quillen,Kathleen T. Finn,John L. Berk,Laura M. Dember,Rodney H. Falk,Martha Skinner
Late effects in survivors of chronic myeloid leukemia treated with hematopoietic cell transplantation: results from the Bone Marrow Transplant Survivor Study
Clinical Trials & Observations
K. Scott Baker,James G. Gurney,Kirsten K. Ness,Ravi Bhatia,Stephen J. Forman,Liton Francisco,Philip B. McGlave,Leslie L. Robison,David S. Snyder,Daniel J. Weisdorf,Smita Bhatia
CORRESPONDENCE
-
Cover Image
Cover Image
Advertisement intended for health care professionals
Email alerts
Advertisement intended for health care professionals